TYRO3 and hepatocellular carcinoma: For example, TYRO3 mRNA levels were increased by 2-fold or greater in approximately 40% of hepatocellular carcinoma patient samples compared to adjacent normal liver tissue and in a panel of human liver cancer cell lines relative to a normal hepatocyte cell line [45].